Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA166171
Max Phase: Preclinical
Molecular Formula: C50H57NO15
Molecular Weight: 912.00
Molecule Type: Small molecule
Associated Items:
ID: ALA166171
Max Phase: Preclinical
Molecular Formula: C50H57NO15
Molecular Weight: 912.00
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccc(C(=O)c5ccccc5)cc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C
Standard InChI: InChI=1S/C50H57NO15/c1-26-32(63-44(59)39(56)36(51-45(60)66-46(3,4)5)28-19-21-30(22-20-28)37(54)29-15-11-9-12-16-29)24-50(61)42(64-43(58)31-17-13-10-14-18-31)40-48(8,41(57)38(55)35(26)47(50,6)7)33(53)23-34-49(40,25-62-34)65-27(2)52/h9-22,32-34,36,38-40,42,53,55-56,61H,23-25H2,1-8H3,(H,51,60)/t32-,33-,34+,36-,38+,39+,40-,42-,48+,49-,50+/m0/s1
Standard InChI Key: OMQAQZGDRCRRBT-UPTBTMBVSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 912.00 | Molecular Weight (Monoisotopic): 911.3728 | AlogP: 4.49 | #Rotatable Bonds: 10 |
Polar Surface Area: 241.52 | Molecular Species: NEUTRAL | HBA: 15 | HBD: 5 |
#RO5 Violations: 2 | HBA (Lipinski): 16 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 11.87 | CX Basic pKa: | CX LogP: 4.38 | CX LogD: 4.38 |
Aromatic Rings: 3 | Heavy Atoms: 66 | QED Weighted: 0.08 | Np Likeness Score: 1.63 |
1. Bourzat J, Lavelle F, Commercon A. (1995) Synthesis and biological activity of Para-substituted 3-phenyl docetaxel analogs, 5 (8): [10.1016/0960-894X(95)00118-D] |
2. Sivakumar PM, Naga Vignesh, Ramesh Kumar G, Doble M. (2012) Computational approaches to enhance activity of taxanes as antimitotic agent, 21 (9): [10.1007/s00044-011-9779-x] |
Source(1):